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Background: Many biomedical publications refer to data obtained from collections of biosamples. Sharing such
bioresources (biological samples, data, and databases) is paramount for the present governance of research.
Recognition of the effort involved in generating, maintaining, and sharing high quality bioresources is poorly
organized, which does not encourage sharing. At publication level, the recognition of such resources is often
neglected and/or highly heterogeneous. This is a true handicap for the traceability of bioresource use. The aim of
this article is to propose, for the first time, a guideline for reporting bioresource use in research articles, named
CoBRA: Citation of BioResources in journal Articles.
Methods: As standards for citing bioresources are still lacking, the members of the journal editors subgroup of the
Bioresource Research Impact Factor (BRIF) initiative developed a standardized and appropriate citation scheme for
such resources by informing stakeholders about the subject and raising awareness among scientists and in science
editors’ networks, mapping this topic among other relevant initiatives, promoting actions addressed to stakeholders,
launching surveys, and organizing focused workshops.
Results: The European Association of Science Editors has adopted BRIF’s suggestion to incorporate statements on
biobanks in the Methods section of their guidelines. The BRIF subgroup agreed upon a proposed citation system:
each individual bioresource that is used to perform a study and that is mentioned in the Methods section should
be cited as an individual “reference [BIORESOURCE]” according to a delineated format. The EQUATOR (Enhancing
the QUAlity and Transparency Of health Research) network mentioned the proposed reporting guideline in their
“guidelines under development” section.
Conclusions: Evaluating bioresources’ use and impact requires that publications accurately cite such resources.
Adopting the standard citation scheme described here will improve the quality of bioresource reporting and will
allow their traceability in scientific publications, thus increasing the recognition of bioresources’ value and relevance
to research.
Please see related article: http://dx.doi.org/10.1186/s12916-015-0284-9.
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Sharing bioresources: needs and impediments
Bioresources are collections of data and/or samples that
are scientifically built and systematically documented.
These include physical resources like human biobanks
with associated health information, databases, plant
and animal repositories, registries, and bioinformatics
tools. Although an increasing proportion of biomedical
research relies on bioresources, these are seldom shared
[1]. In clinical research, for instance, nearly half of trials
remain unpublished [2]. In some instances, data sharing
may be prohibited to protect subject/patient/victim con-
fidentiality, proprietary interests or national security, or
for political reasons, but these are very specific cases.
Most of the time, sharing does not occur because it entails
a long and time-consuming process that is far from
fully appreciated and which is hardly recognized by
stakeholders.
Sharing bioresources does not simply involve providing
access to other users. Good sharing requires specific work
on metadata, on quality control for data and samples man-
agement, and on documentation. Sharing also requires
regular bioresource updating and the development of a
clear access policy. This work is not trivial. It is neither
recognized and valued in the present academic world
nor considered an important aspect in the processes of
evaluation. This lack of recognition is a major obstacle
to sharing. The more difficult, costly, time-consuming,
and highly specialized the development of a useful bior-
esource is, the more researchers and institutions will
expect recognition for their usefulness. If the scientific
community does not value this work, it is unlikely to be
performed adequately.
Sharing research outputs, data, and resources contributes
to building reliable knowledge and generating innovation.
This is now supported by funding agencies that foster data
sharing, especially in health research [3]. The European
Commission emphasizes that research data are as import-
ant as publications, and it has committed to openness in its
present funding scheme, Horizon 2020 [4]. A number of
initiatives are being developed to encourage exploiting
existing healthcare databases and exchanges in the medical
world [5]. Initiatives of interest include the Canadian
Network for Observational Drug Effect Studies [6] and
the initiative for Quality Assessment of Administrative
Data [7] of the Institute for Clinical Evaluative Sciences.
Some journals, including Annals of Internal Medicine
[8], provide guidance on data sharing and a number of
authors have published articles addressing the issue of
sharing health data [9,10].
However, these kinds of initiatives mainly concern
patient/trial data, and no standard exists regarding the
use of bioresources in general [1,11,12]. One potential
solution, outlined in this article, is to develop a way toincentivize the biomedical community through harmo-
nized citation and recognition processes.
Why do we need a standard for bioresource citation?
As explored in a previous article [1], it is extremely difficult
to identify the contribution of any specific bioresource to
research published in scientific articles because biore-
sources are either cited in a confusing, heterogeneous, and
unstandardized way, or they are not cited at all.
In most cases, due to the current modalities of citation,
the use of a bioresource in a research article (summarized
below) is not retrievable via PubMed or other bibliographic
databases, which only index abstracts. This does not allow
proper traceability and visibility of bioresources in scientific
literature or in other (online) sources that would highlight
their use and thus encourage bioresource sharing. For in-
stance, an analysis published in 2011 showed that half
of the papers published in biomarkers research con-
tained no information about the biospecimens used [13].
The points below summarize some of the negative effects
of citation heterogeneity on the tracking of bioresource use,
and the limitations generated by this situation. Adopting a
citation standard would bring several advantages, which are
also outlined.
Current modes of bioresource citation
 Bioresources may be acknowledged in various
sections, including Materials and Methods,
Acknowledgements, and References
 Bioresource acknowledgements or citations may be
placed outside the main paper, or in online
supplementary materials
 Citations may acknowledge different resource levels,
for example, citation of the consortia or network,
but not the individual bioresource
 Secondary use, such as the use of derivatives from the
original bioresource (i.e., extracts from biospecimens)
 Typing errors or approximation of the bioresource
name/identification; a multiplicity of names for a given
bioresource; various names in different languages
 Acknowledgement of persons and authorship
instead of the bioresource itself
 Absence of bioresource citation (negligence)
 Websites: reference to web sites that no longer exist,
are not updated, or are not informative
 Absence of a Material Transfer Agreement or Data
Transfer Agreement number and/or report information
on the access(es)
Effects of variations in bioresource citations on tracking
bioresource use
 Full-text mining is required to trace bioresource use
Bravo et al. BMC Medicine  (2015) 13:33 Page 3 of 12 No traceability
 Difficult or impossible to recognize the use and
contribution of individual bioresources
 Disregarded criteria for correct reporting
 At worst, no tracking is possible if there is no
citation at all
 Misleading or incomplete information about
bioresource use
Effect of the lack of standardized citations
 Bioresources are not indexed in PubMed or Web of
Science
 Incomplete information of the bioresources used in
research articles
 Lack of recognition and traceability
 Studies may be impossible to replicate by others
 No information on the number and type of
biosamples, the amount of associated data, or the
data exchanged between the biobank and the user
 Limited ability to develop accurate indicators of
bioresource activity
 Limited ability to adopt suitable policy for
stakeholders at any level
 Underestimation of the utility of bioresources
Advantages of standardized citation
 The possibility to search literature for the use of a
bioresource
 Available information about bioresource use
 Development of indexing tools in PubMed and Web
of Science to track the use of bioresources
 Support for the development of metrics to assess
bioresource impact
 Facilitation of stakeholders’ work (e.g., policy,
decision-making, assessment, etc.)
 Increased recognition of infrastructure and institutions
involved in creating and maintaining a bioresource
 Improved specific knowledge of biospecimens and
databases used in research articles
 Increased sharing of data and biological samples
 Improved trust of bioresource contributors
including patients and donors
To track publications involving a bioresource, it is
essential that researchers consistently acknowledge the
use of the bioresource by placing unique and traceable
information in all relevant publications in a defined
section of the article. Ideally, this information should
include an actionable digital identifier (ID) assigned to the
bioresource. To date, such an ID is not available. In order
to fulfil the requirements of the scholarly record, a biore-
source ID should be persistent, globally unique, citable,and easily retrievable through the Internet. There is major
debate over which body or bodies should be responsible
for assigning and managing bioresource IDs [11].
The systematic and standardized citation of bioresources
in journal articles is needed for the fair recognition of
the impact of bioresources on health research, both in
qualitative and quantitative terms. While textual resource
citation follows clear editorial guidelines, citation rules for
bioresources are yet to be defined. Most current initiatives
address data sharing policies or technical aspects of
sharing, such as interoperability, quality of data, and
standards for data management, but not the recognition
of the work required in data sharing and the traceability
of such sharing [1,14,15]. However, a recent initiative
by publishers has begun to address this issue [16]. The
Bioresource Research Impact Factor (BRIF) initiative has
taken the lead on activities aimed toward standardizing
the bioresource citation process, together with biomedical
editors [17,18] and other scientific organizations involved
in bioresource monitoring and sharing. This process of
collaboration and its principal outcomes will be discussed
in detail in the following paragraphs.
The BRIF initiative
The BRIF initiative [19] is an on-going international
framework, the major features of which are summarized
in Table 1. Five dedicated working subgroups deal with
priority tasks: adapting ways of identifying bioresources,
parameters to consider when calculating impact, standard-
ized ways of citing bioresources in scientific literature,
the embedding of BRIF in data sharing policies, and dis-
semination. The “BRIF and Journal Editors” subgroup
first established connections with editors to standardize
bioresource citation. The next phase is to implement
BRIF, once it has been assessed, with a specific task
being to assess proposals for amending available editorial
guidelines. The subgroup gathers three editorial experts
and two biomedical researchers involved in biobank-
ing based at the National Institute of Health (Istituto
Superiore di Sanità) in Italy, as well as the BRIF leader and
manager, who are from a joint research unit between
the French National Institute for Health and Medical
Research (Inserm) and the University Toulouse III. All
members of the workgroup are involved in coordinating
the work carried out with journal editors and in leading
the development of a guideline for bioresource citation
in the scientific literature.
Steps
Developing a guideline for bioresource citation (CoBRA)
The actions of the “BRIF and Journal editors” subgroup
were divided into two phases. The first phase aimed at
disseminating information about the BRIF initiative among
the scientific community and attracting the attention of
Table 1 The BRIF initiative [1,12,19]
Organization and multidisciplinary competences
The BRIF initiative is developing a framework to recognize and measure the use and impact of biological resources in health research. The BRIF
working group consists of 135 members from 22 countries, most of whom are either European (86) or North-American (31). A broad range of
experts are participating, including biobankers, clinicians, genomic/genetic scientists, epidemiologists, computer scientists, jurists, lawyers,
ethicists, experts in information, bibliometricists, and journal editors; they are represented in different BRIF subgroups.
General aims • Promoting the sharing of data and biological samples
• Recognizing the work (human resources/infrastructure) involved in setting up and maintaining a valid bioresource
• Providing more complete information on the bioresources used in research
Strategies • Standardizing the citation of bioresources in scientific articles in order to trace their use on the web
• Creating a tool (BRIF indicator) to establish the frequency of a bioresource’s use and evaluate its impact based
on quantitative metrics and on the use of a unique digital resource identifier (ID)
Working subgroups
• BRIF and digital identifiers Exploring and assessing existing and emerging technical solutions suitable for bioresource identification, as well
as addressing key related questions, including what to identify (biobank projects, sample collections, databases,
datasets, registries) and which body or bodies should be responsible for assigning bioresource IDs
• BRIF parameters Identifying potential factors to take into account when calculating the BRIF indicator
• BRIF in sharing policies Developing an appropriate set of recommendations (BRIF procedure) to consider in developing and implementing
bioresource access and sharing policies
• BRIF and Journal editors Relating with scientific journal editors to standardize bioresource citation in journal articles and amending the
corresponding editorial guidelines
• BRIF dissemination Communication and dissemination of information related to the BRIF initiative
Pilot projects
To support the adoption of bioresource citation standards, BRIF participates in two pilot projects:
• The creation of the open access journal Open Journal of Bioresources [20], which publishes peer reviewed articles (‘marker papers’) that describe
bioresources in detail according to a standardized template. The Digital Object Identifier of the marker paper can identify the bioresource and
provide a way of automatically tracking the use of bioresources in academic literature
• Testing the use of a unique bioresource ID in the research community, attributed through the Public Population Project in Genomics and Society [21]
in partnership with the European project BioSHaRE (Biobank Standardisation and Harmonisation for Research Excellence in the European Union) [22].
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about proper reporting and sharing of bioresources.
The second phase focused on the practical development
of a standard for the “Citation of BioResources in journal
Articles” (CoBRA). The structure of the guideline was
developed according to the general principles reported by
Moher et al. [23].
Disseminating information on BRIF to science editors
In 2012, the “BRIF and Journal editors” subgroup agreed to
submit proposals to international associations, editorial
committees, and other professional organizations, with
the aim of attracting their attention on issues related to
bioresources, creating awareness of the BRIF initiative, and
eventually of amending editorial guidelines by including a
reference to bioresources.
First, the subgroup contacted the International Com-
mittee of Medical Journal Editors (ICMJE), a group of
general medical editors and representatives of related
organizations who evaluate how to improve the quality
of medical science and reporting by updating their
recommendations [24]. The aim of this action was to sug-
gest amendments concerning standardized bioresource
citations to be included in a revised version of theICMJE Recommendations for the Conduct, Reporting,
Editing, and Publication of Scholarly Work in Medical
Journals (at that time named Uniform Requirements
for Manuscripts Submitted to Biomedical Journals
[25]). The subgroup thoroughly analyzed the ICMJE
recommendations and suggested specific amendments.
Second, the subgroup examined the Guidelines for
Authors and Translators of Scientific Articles produced
by the European Association of Science Editors (EASE),
an internationally oriented community of individuals from
diverse backgrounds, linguistic traditions, and professional
experience who are interested in science communication
and editing. EASE guidelines are well known by science
editors not only in Europe but also globally, thanks to
their translation into 22 languages [26]. The subgroup
identified specific sections where these guidelines might
include standardized bioresource citations. During the
11th EASE General Assembly and Conference, “Editing in
the Digital World,” held in Tallinn in 2012 [27], these
proposed amendments were presented and discussed.
Third, the subgroup also approached the Committee
on Publication Ethics (COPE), an important forum for
editors and publishers of peer reviewed journals, which
advises editors on handling cases of research and
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COPE to consider the editorial and ethical problems
concerning biobanks and bioresources in general.
Fourth, the subgroup contacted the Enhancing the
QUAlity and Transparency Of health Research (EQUA-
TOR) Network, which works to improve the reliability
and value of medical research literature by promoting
transparent and accurate reporting of research studies,
in order to discuss how a standard for bioresource cit-
ation currently in development could be announced and
reported on the EQUATOR website [28].
In pursuing these steps, the subgroup participated in
a number of international meetings and events. The
preliminary work of disseminating information on BRIF
initiatives was achieved through a lecture at the 5th
Belgrade International Open Access Conference in 2012
[29] and a poster at the 11th EASE General Assembly and
Conference, described above [27]. Given the interest gen-
erated, the subgroup targeted other potentially interested
key communities by participating in their international
meetings and events. In the science editing community,
this included:
 The Seventh International Congress on Peer Review
and Biomedical Publication, 2013, Chicago, USA;
 The Eurosurveillance Editorial Board Meeting, 2013,
Vilnius, Lithuania;
 The 12th EASE General Assembly and Conference,
2014, Split, Croatia;
 The 14th European Association for Health
Information and Libraries Conference, 2014,
Rome, Italy.
In addition, the subgroup presented the BRIF initiative
in scientific conferences attended by scientists who work
with large databases and/or collections, including:
 The European Human Genetics Conference, 2013,
Paris, France;
 The Brocher Workshop Exploring Innovative
Mechanisms to Build Trust in Human Health
Research Biobanking, 2013, Geneva, Switzerland;
 The “HandsOn: Biobanks 2013” Conference, The
Hague, Netherlands;
 The 28th European Immunogenetics and
Histocompatibility Conference, 2014, Stockholm,
Sweden;
 The 5th Biennial Meeting of the Human Variome
Project, UNESCO, 2014, Paris, France;
 The “HandsOn: Biobanks 2014” Conference,
Helsinki, Finland;
 The ESBB (European, Middle Eastern and African
Society for Biopreservation and Biobanking) annual
meeting, 2014, Leipzig, Germany.Informal contacts and discussions occurred during these
events, increasing the dissemination of information. The
topic was always well received, and the subgroup was
encouraged to continue.
Developing a guideline for bioresource citations
In 2013, based on the experiences above, the “BRIF and
Journal editors” subgroup decided to further explore how
clear bioresource citation guidelines could be established
with the help of journal editors. A survey was presented
to a sample of biomedical editors in order to identify key
science editors who would be interested in the initiative
and who would contribute to its advancement. In order
to test the feasibility of the approach, the survey was
addressed initially to 50 editors of journals, both open
access and traditional subscription-based, that are indexed
in the Web of Science and that have a range of impact
factors. Subsequently, to diversify the sample, a second
group of 40 editors were contacted, identified according
to the same criteria. The survey response rates were 22%
and 17.5% for the first and second groups, respectively.
The survey questions were as follows:
 Have you ever heard about the issues of
bioresources evaluation and their standardized
citations in biomedical journals?
 Do you think this is a topic of interest for the
editorial policy of your journal?
 Would you agree to address this issue in the
Instructions to Authors?
 A meeting will be held in Rome (June 21, 2013) to
discuss about this matter. Would you like to receive
more information?
 Would you consider participating in this meeting?
Interested editors identified by the survey were invited
to participate in a workshop organized in Rome, Italy, in
June 2013.
At the Rome meeting [30], participants were split into
two working groups selected to balance individual com-
petences and to facilitate individual contributions to the
debate. Participants were asked to discuss proposals
including the following as potential recommendations to
authors in journal guidelines:
 A unique identifier for each biobank – or
bioresource – that could be used as a form of citation;
 A dedicated “bioresource section or field,” analogous
to the existing “author section” or “author field” that
authors are required to complete during the article
submission process, which would require authors to
include specific metadata characterizing the
bioresource used and thereby allowing its easy
tracing;
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bioresource(s).
Results
Engaging the science editing network
EASE agreed to incorporate statements on biobanks in
the “Methods” section of the EASE Guidelines published
in 22 languages [26]. The answers from ICMJE and from
COPE oriented the “BRIF and Journal editors” subgroup
action toward EQUATOR. According to EQUATOR’s
positive evaluation of a standard for reporting bioresource
use, the subgroup decided first to develop the standard
before contacting other key organizations such as the
World Association of Medical Editors, the Council of Sci-
ence Editors, and the Board of Editors in Life Sciences.
Developing a standard for bioresource citation
The discussion at the 2013 BRIF workshop in Rome
focused the subgroup on a new and practical approach
to the issue of bioresource citation. In this sense, the
meeting was a turning point. Initially, the main objective of
the meeting was to develop a consensus recommendation
for standardized bioresource citation. Three leading pro-
posals for bioresource citations in journal articles were
presented to the two workshop groups, as discussed above:
1. The use of a unique ID for bioresources;
2. The possibility of a “bioresource field” as editorial
metadata;
3. The use of specific acknowledgement sentences.
A subsequent general discussion combined and har-
monized the final remarks elaborated by the two groups.
The discussion was very lively, several issues were exam-
ined, and new proposals were suggested.
The editors shared their points of view about integrat-
ing new editorial elements regarding bioresources and
stressed how difficult it is to satisfy each stakeholder in
journal articles, including authors, readers, resource pro-
viders, and editors. They agreed that bioresources should
be cited in a standardized/harmonized way, favoring the
easiest implementation routes such as using editorial
processes familiar to the scientific community and pre-
existing solutions that are easy to adapt to the specific
case of bioresources.
Regarding the three proposals under discussion, the
participating editors agreed that:
 Identifying bioresources using an ID rather than the
name of the bioresource would be better to avoid
confusion, but that such an ID is not yet generally
available;
 A “bioresource field” or a specific section is not an
appropriate solution, because it would be toocomplicated and not of sufficiently broad use to
warrant its creation;
 Referring to bioresources in the Methods section
seemed the most appropriate solution, provided
that the reference corresponds to a cited reference
(see below);
 Specific sentences in the Acknowledgement section
in journal articles did not seem useful, considering
the necessity of traceability and easy retrieval.
The work and discussion among the editors and the sci-
entists created a new paradigm that takes into account
standardization and traceability by adopting the simplest
solutions among currently existing options. The core idea
is to cite each bioresource used in a research work as a
reference. To identify the bioresource in the reference, an
immediate solution would be to use an ID such as a Digital
Object Identifier (DOI) corresponding to the publication
that describes the bioresource in detail (marker paper), or
the bioresource catalogue ID. Initiatives such as the Open
Journal of Bioresources [20] or the Biopreservation and
Biobanking journal [31] that provide bioresource descrip-
tions were determined to be suitable tools for referring to
bioresources, although not all bioresources are currently
described in corresponding marker papers. The biore-
source identifier could then be tracked through CrossRef
[32]. According to this proposal, the “Reference” section in
the journal article is responsible for the actual task of bior-
esource citation. This proposal has the advantage of being
familiar to researchers, editors, and publishers.
The editors attending this meeting also provided sugges-
tions about where exactly to cite bioresources in journal
articles and recommended that guidelines to authors
should be revised accordingly. Given the lack of guidelines
specifically related to bioresource citation, and following
the suggestion of the ICMJE, the “BRIF Journal editors”
subgroup approached the EQUATOR Network and sub-
mitted the guideline proposal for EQUATOR’s “Reporting
Guidelines under Development” section. The request was
accepted and the project of a guideline was posted in
October 2013 [28].
The proposal for the specific reference scheme to report
the use of bioresources was presented and discussed during
the Seventh International Congress on Peer Review and
Biomedical Publication in September 2013 [33]. This was
an opportunity to discuss the issue with the biomedical
journal editors, in particular with those involved in the
reporting of clinical trials, following which began the elab-
oration of a specific guideline for standardized bioresource
citation. Dissemination of such a proposal was treated as a
continuous process aimed at collecting feedback from
interested communities to develop the guideline adequately
up until its endorsement. The resultant consensus, span-
ning many different scientific contexts, regarding the
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bioresources persuaded the subgroup to propose a
guideline on how this information should be reported
in scientific papers.
Guideline for the standardized citation of bioresources in
journal articles (CoBRA)
Each bioresource cited in the Methods section of a re-
search article must refer to an individual reference that
follows a specific format as described below. The check-
list for standardized bioresource citation is reported in
Table 2 with further explanation.
Examples of the different cases for bioresource citation
are given in Box 1.
Bioresources may be cited in a scientific article for two
reasons:
 USE: The bioresource has been used as a source of
samples and/or data to perform the study;
 NO-USE: It is necessary to cite a bioresource in the
article, but the bioresource was not a source of
materials for the study.
In both cases, the “citation” of the bioresource will be
implemented following CoBRA indications, but the “use”
of the bioresource in the reported study will be specified
within the citation by adding “[BIORESOURCE]” at the
end of the reference.
USE: Citing a used bioresource. The reference has
the following format:
Identification (ID and/or DOI, Bioresource name,
Acronym (if available); (if applicable) Organization (net-
work partnership or membership); Number (No) of
access(es)/Date of last access; [BIORESOURCE].
NO-USE: Citing a bioresource that was not used.
The reference has the following format:
Identification (ID and/or DOI, Bioresource name,
Acronym if available); (if applicable) Organization (network
partnership or membership).
An example of these different uses is provided in Box 1,
Example 5. If the bioresource used is a digital resource
(for example, a database, dataset, or registry) only the last
access should be reported. For the sections authorship,
acknowledgements, and/or editorial policies, the authors
should refer to the instructions for authors of the journal.
Expected impact of the adoption of CoBRA guidelines
The driving principle of this work is that bioresources
must be cited in a standardized and retrievable way in
order to acknowledge their value and highlight their use
in research achievements. The proposed guidelines were
formulated with extensive stakeholder involvement and
through a long process of consultation and dissemination,
as described. These interactions raised awareness andcreated consensus on the importance of standardized
citations as a tool to measure the impact of bioresources
on research production. The main advantages of the adop-
tion of standardized citations are summarized in the
Advantages of standardized citation section above.
The identification of bioresources through a unique
digital ID should be preferred. However, due to the absence
of governing bodies in charge of assigning and managing
bioresource IDs, few bioresources currently have such an
ID. This may soon change, at least in Europe. The principle
of assigning a unique ID to biobanks has been adopted
by the Biobanking and Biomolecular Resources Research
Infrastructure (BBMRI), which was officially awarded the
community legal framework for a European Research
Infrastructure Consortium (ERIC) on the 3rd of December,
2013 [34]. The mission of BBMRI-ERIC [35] is to facilitate
access to and use of high quality human biological re-
sources. Thus far, 12 European countries have already
signed agreements to participate, and more countries are
expected to join in 2015. An ERIC institution in biobanking
provides relevant new perspectives because ERIC is an
internationally recognized legal entity that has operational
sites (“National Nodes”) in multiple countries. ERIC institu-
tions operate under unique legislation, and the long-term
economic sustainability of the consortium is ensured by
member states’ annual fees [36].
At present, an increasing number of bioresources pub-
lish a corresponding paper that describes the bioresource
in detail. In the absence of a unique ID for the resource
itself, the DOI corresponding to this descriptive publica-
tion may be used as identifier (see Box 1, Example 2).
Identification of a bioresource though a digital identifier
(ID/DOI) instead of its name will improve web tracking
because i) it allows the standardization of the bioresource
tracking process and the use of automated systems, and ii)
it enables bioresources to be tracked through CrossRef [32].
Bioresources may partner with networks or consortia
and/or they may be members of organizations. Biore-
sources should mention such partnerships in scientific
publications. The reference format proposed allows this
(see Box 1, Examples 2 and 3).
BRIF’s concept and the effort to standardize bioresource
citation are in line with the multiple initiatives that sup-
port open access to research results. A proper bioresource
citation system would foster a climate of trust and trans-
parency among all parties involved in research biobanking,
from patients to funding bodies and policymakers.
The European Commission policy encourages data shar-
ing and reuse. This policy is at the basis of the recently con-
stituted European BBMRI-ERIC [35], which is including
several axes of the BRIF initiative in its work plan – a major
step in BRIF implementation. It is necessary to implement
systematic reward and recognition mechanisms for sharing
data and materials. The sharing of, or reuse of stored
Table 2 CoBRA checklist for the citation of bioresources used* in scientific journal articles
Article text section Item # Guidance Additional information
Abstract 1 Indicate whether the work has used one or more bioresources;
specify the number of bioresources if relevant
Adapt according to the number of words allowed
Introduction 2 Indicate that the work has used one or more bioresources; specify the type The types of bioresources include: data, samples and data, database, registry
Methods 3 Report each individual bioresource used to perform the study: The format of the reference is detailed in item 6 in the section “References”
By their name and other ID, if extant The bioresource name should be the original name as reported in
By a single bibliographic reference Official documents such as Material Transfer Agreement (MTA) and Data
Transfer Agreement (DTA); the name should be reported in the original
language without translation
Specify any relevant characteristics of the bioresource, such as sample
number and type of biospecimens, if this information is not available
from the bioresource reference
Number of accesses can be also reported here, for instance, as the
MTA/DTA registration number associated with each access; if the dates
of actual bioresource availability for the user (e.g., reception of samples)
are distant from those in the MTA signature, this can be reported here
Results 4 Indicate the relevance of the bioresource(s) used for the study (Optional)
Discussion 5 Standard rules should apply
Reference 6 Cite each bioresource as a reference as follows: Each citation includes three fields: Identification/Institution/Access
ID/Bioresource Name (acronym if available)/organization or network partnership,
membership (optional)/Number of access(es), Date of last access; [BIORESOURCE]
Specifications for ID: Unique ID can be DOI, catalogue number, or the name only
If the only ID is the name then add Town and Country
The “use” of the bioresource is distinguished within the citation by adding
“[BIORESOURCE]” at the end of the reference
ID: citing the ID, rather than, or in addition to, the name is essential in
order to avoid any confusion and facilitate retrieval (see Box 1, Example 1)
DOI: if the detailed description of the bioresource is available in a
marker paper, it should be cited here, this being one way of
providing a DOI (see Box 1, Example 2)
Name: the name should be the original name as reported in official
documents such as MTA and DTA. The name should be reported in
the original language of the residence country without translation
Place of residence (town) and country should be translated in the
article language (See Box 1, Example 3)
Acronym: when available, stable and consolidated, it is recommended
to add the acronym to the reference (See Box 1, Example 3)
If the bioresource requires mentioning membership or partnership in
consortia, networks or organizations, a dedicated field should be included
(see Box 1, Examples 1 to 3)
When the bioresource is a physical resource such as a biobank or collection,
the number of accesses should be specified, in addition to the date of last access.
These data will generally correspond to the data signature of the MTA/DTA
When the bioresource is a digital resource such as a database, dataset,












Table 2 CoBRA checklist for the citation of bioresources used* in scientific journal articles (Continued)
Authorship 7 Standard rules should apply
Providing samples or data is not sufficient to justify authorship
Acknowledgements 8 Standard rules should apply
*In the case of bioresources not used as a source of material for the study, but only referred to, follow the citation format: ID/Bioresource Name (acronym if available)/organization or network partnership, membership












Box 1. Examples of how to cite a bioresource in the references of articles
- All examples assume that the bioresource was actively used to complete the research (“USE” condition) except Example 5 case 1.
- Examples assume that two different accesses to the bioresource occurred, one on March 3, 2013 and one on April 15, 2014.
- Examples 1, 2, and 3 assume that cited bioresources are committed to report their partnership with BBMRI-ERIC.
- Acronyms will be added only in cases of consolidated use by the biobank.
Example 1: The bioresource has an ID and a consolidated acronym
Bioresource: Microisolates in South Tyrol Study (MICROS), Bolzano, Italy; ID: BRIF2155.
Citation: BRIF2155; Microisolates in South Tyrol Study (MICROS); BBMRI-ERIC; No. Access: 2, Last: April 15, 2014. [BIORESOURCE]
Example 2: The bioresource has been described by a marker paper with a DOI, and has a consolidated acronym
Bioresource: The Australian Breast Cancer Tissue Bank (ABCTB), Australia.
Citation: Carpenter JE, Marsh D, Mariasegaram M and Clarke CL. The Australian Breast Cancer Tissue Bank (ABCTB). Open Journal
of Bioresources 1:e1; 2014. DOI: http://dx.doi.org/10.5334/ojb.aa; No. Access: 2, Last: April 15, 2014. [BIORESOURCE]
Example 3: The bioresource does not have a DOI, nor an ID
Bioresource: BioBanca Istituzionale of Naples, Italy.
Citation: BioBanca Istituzionale (BBI), Naples, Italy; BBMRI-ERIC; No. Access: 2, Last: April 15, 2014. [BIORESOURCE]
Example 4: The bioresource is a database that has been used to realize the research
Bioresource: Orphanet.
Citation: Orphanet; Le portail des maladies rares et des médicaments orphelins; Last access: April 15, 2014. [BIORESOURCE]
Example 5: The bioresource has a DOI and has to be cited
Case 1: NO-USE: Citation for any case but “use” of the bioresource.
Citation: Consuegra I, Jimenez J L, D. The Spanish HIV HGM BioBank (SHIVBB). Biopreservation and Biobanking. 2013, 11(4): 253–254.
doi:10.1089/bio.2013.1133.
Case 2: USE: Citation for a bioresource that contributed to the article with biosamples and/or data.
Citation: Consuegra I, Jimenez J L,D. The Spanish HIV HGM BioBank (SHIVBB). Biopreservation and Biobanking. 2013, 11(4): 253–254.
doi:10.1089/bio.2013.1133; No. Access: 2, Last: April 15, 2014. [BIORESOURCE]
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key to developing scientific knowledge. Consistently and
easily citing sources facilitates their recognition and makes
their impact measurable, as with traditional manuscript
publications. The standardized citation proposed in this
guideline allows the efficient retrieval of the bioresources
used in journal articles. It is a “ready to use” tool for begin-
ning to measure bioresource impact.
In human health studies, bioresource use is at the base
of translational research development. The adoption of
standardized bioresource citations and the BRIF initiative
(Table 1) is in harmony with the needs of public health
systems to improve quality and to develop cost affordable
indicators of outcomes [37]. The implementation of a cit-
ation schema also has the advantage of not creating any
additional cost for researchers and stakeholders. Initiatives
such as The Biospecimen Reporting for Improved Study
Quality, which are recommendations intended to improve
the quality of research in which human biospecimens are
used, are very useful [38] and the CoBRA guideline pro-
posed for citations is complementary to them.
The authors expect that the CoBRA guideline will be
published in the reporting guidelines of the key websiteEQUATOR [28]. In fact, the CoBRA standard is consistent
with all of the guidelines currently published in EQUA-
TOR and can be used in combination with any of them.
For example, a randomized trial involving the use of a
bioresource should use the CONSORT guideline [39] in
order to decide which information to include about the
trial (including trial design, participants, sample size,
randomization, and so on) and the CoBRA guideline in
order to properly cite the bioresource(s) used according to
the standard format.
Conclusions
Evaluation of bioresource use and impact in research
requires accurate citation of such resources in publications.
Editors, as gatekeepers of scientific information, and au-
thors as providers of such information, must be proactive
in applying CoBRA as a standard citation scheme for biore-
sources. The use of CoBRA will improve the quality of
bioresource reporting and will allow bioresource traceability
in scientific publications, encouraging policies of collabor-
ation and sharing. The endorsement and the adoption of
the CoBRA guideline by authors, editors, researchers, and
bioresource policy stakeholders is the first necessary step
Bravo et al. BMC Medicine  (2015) 13:33 Page 11 of 12to achieve these goals and is essential to enhance transpar-
ency in health research.
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